Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Key advances in the treatment of lymphoma from ASH 2010

Prof Mathias Rummel, Dr Umberto Vitolo, Prof Johannes Drach, Prof Christian Buske, Prof Owen O'Connor

Key advances in the treatment of lymphoma from ASH 2010 ( Prof Mathias Rummel, Dr Umberto Vitolo, Prof Johannes Drach, Prof Christian Buske, Prof Owen O'Connor )

First-line Indolent Trial (FIT) study

Prof Anton Hagenbeek - Academic Medical Center, Amsterdam, Netherlands

First-line Indolent Trial (FIT) study ( Prof Anton Hagenbeek - Academic Medical Center, Amsterdam, Netherlands )

Key research presented at ASH 2010

Prof George Canellos - Harvard Medical School, Boston, USA

Key research presented at ASH 2010 ( Prof George Canellos - Harvard Medical School, Boston, USA )

The role of comorbidity indices in the prognosis of elderly MDS patients

Prof Valeria Santini - University of Florence, Italy

The role of comorbidity indices in the prognosis of elderly MDS patients ( Prof Valeria Santini - University of Florence, Italy )

Burkitt’s lymphoma in the elderly

Dr Antonio Pinto - Fondazione ‘G. Pascale’, Naples, Italy

Burkitt’s lymphoma in the elderly ( Dr Antonio Pinto - Fondazione ‘G. Pascale’, Naples, Italy )

Changing the paradigm in frontline CML therapy

Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network

Changing the paradigm in frontline CML therapy ( Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network )

ENESTnd trial comparing nilotinib and imatinib as first line CML therapy

Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia

ENESTnd trial comparing nilotinib and imatinib as first line CML therapy ( Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia )

Haematological cancers in the elderly

Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria

Haematological cancers in the elderly ( Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria )

The importance of myelodysplastic syndrome diagnosis

Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria

The importance of myelodysplastic syndrome diagnosis ( Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria )

Key lymphoma research from ASH 2010

Prof Wyndham Wilson - National Cancer Institute, Maryland, USA

Key lymphoma research from ASH 2010 ( Prof Wyndham Wilson - National Cancer Institute, Maryland, USA )

The DASISION chronic myeloid leukaemia trial

Dr Neil Shah - University of California, San Francisco, USA

The DASISION chronic myeloid leukaemia trial ( Dr Neil Shah - University of California, San Francisco, USA )

CLL related research from ASH 2010

Dr Michael Keating- MD Anderson Cancer Center, Texas, USA

CLL related research from ASH 2010 ( Dr Michael Keating- MD Anderson Cancer Center, Texas, USA )

More from ecancer